The European Tribune is a forum for thoughtful dialogue of European and international issues. You are invited to post comments and your own articles.
Please REGISTER to post.
At least five of the candidate COVID-19 vaccines use one of two human fetal cell lines: HEK-293, a kidney cell line widely used in research and industry that comes from a fetus aborted in about 1972; and PER.C6, a proprietary cell line owned by Janssen, a subsidiary of Johnson & Johnson, developed from retinal cells from an 18-week-old fetus aborted in 1985. Both cell lines were developed in the lab of molecular biologist Alex van der Eb at Leiden University.
Covid drug given to Trump developed using cells derived from aborted fetus | The Guardian |
The 2020 Republican party platform explicitly opposes embryonic stem cell research, and calls for a ban on federal funding for embryonic stem cell research.
"We stopped the federal funding of fetal tissue research, which everybody felt was so important ..." the president told supporters in January 2020. "We're standing up to the pro-abortion lobby like never before.
The HEK-293T line of cells has been "immortalized", meaning they divide freely in the lab. Regeneron said the company does not consider the cells "tissue".
Development of the Regeneron antibody cocktail is supported by a $450m grant from the Biomedical Advanced Research and Development Authority (Barda).
This President is DOOMED! Where's John Hagee?? Oops, infected with SARS Covid-2.
Governor Whitmer of Michigan has done a terrible job. She locked down her state for everyone, except her husband's boating activities. The Federal Government provided tremendous help to the Great People of Michigan. My Justice Department and Federal Law Enforcement announced...— Donald J. Trump (@realDonaldTrump) October 9, 2020
Governor Whitmer of Michigan has done a terrible job. She locked down her state for everyone, except her husband's boating activities. The Federal Government provided tremendous help to the Great People of Michigan. My Justice Department and Federal Law Enforcement announced...
A fourth Phase 3 clinical trial evaluating an investigational vaccine for coronavirus disease 2019 (COVID-19) has begun enrolling adult volunteers. The trial is designed to evaluate if the investigational Janssen COVID-19 vaccine (JNJ-78436725) can prevent symptomatic COVID-19 after a single dose regimen. Up to 60,000 volunteers will be enrolled in the trial at up to nearly 215 clinical research sites in the United States and internationally.
The Janssen Pharmaceutical Companies of Johnson & Johnson developed the investigational vaccine (also known as Ad.26.COV2.S) and is leading the clinical trial as regulatory sponsor. Janssen, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response, are funding the trial.
"Four COVID-19 vaccine candidates are in Phase 3 clinical testing in the United States just over eight months after SARS-CoV-2 was identified. This is an unprecedented feat for the scientific community made possible by decades of progress in vaccine technology and a coordinated, strategic approach across government, industry and academia," said NIAID Director Anthony S. Fauci, M.D. "It is likely that multiple COVID-19 vaccine regimens will be required to meet the global need. The Janssen candidate has showed promise in early-stage testing and may be especially useful in controlling the pandemic if shown to be protective after a single dose."
The Phase 3 trial is being conducted in collaboration with Operation Warp Speed(link is external) (OWS), a multi-agency collaboration overseen by HHS and the Department of Defense that aims to accelerate the development, manufacturing and distribution of medical countermeasures for COVID-19. OWS and CoVPN also are assisting with additional COVID-19 preventive candidate vaccines, including mRNA-1273, an investigational vaccine co-developed by NIAID and the Cambridge, Massachusetts-based biotechnology company Moderna, Inc., and AZD1222, a vaccine candidate being developed by United Kingdom-based biopharmaceutical company AstraZeneca.
Adults who are interested in joining this study can visit Coronaviruspreventionnetwork.org(link is external) or ClinicalTrials.gov and search identifier NCT04505722.
One trial will evaluate the safety and efficacy of the experimental treatment to prevent infection for up to 12 months, in about 5,000 participants, while the second trial will evaluate post-exposure preventative and pre-emptive treatment in roughly 1,100 participants.
Trump credited Regeneron Pharmaceuticals Inc's REGN.O therapeutic for his recovery. Trump received Regeneron's treatment last week after he was diagnosed with COVID-19.
US approval five to seven years of foreign testing.
Longest European delay: Germany six months. Germany re-ran all our test themselves.
Shortest approval: UK. One month, accepted our test reports as gospel. Delay for paper processing.
IIRC France re-ran some tests but not all. Even Italy did some tests.
The blood testing machine sold for about one million dollars but the real money was in the reagent, $10K per liter. Management continually urged us to speed up the tests so the machine would use reagent faster.
Only USA & Europe paid full price for the machine. Maybe Japan. I don't recall us marketing there. Third world got it either greatly reduced or free. Still had to buy the reagent.
Abbott ID NOW CoV-2 molecular point-of-care test for novel coronavirus
May 2020: FDA Alert Inaccuracy Abbott ID NOW
PC software is the worst. "Looks like it works, push it out the door. All software has bugs." Cell phone backbone software is in between." I still remember a hard guideline from a company that shall remain nameless: "Hold onto the line as long as the billing data isn't lost. The last thing to lose is the billing data."
Eli Lilly said that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by President Trump has been paused because of a safety concern https://t.co/bOSVYyTJFE $LLY pic.twitter.com/yekqqn58Qe— Reuters (@Reuters) October 13, 2020
Eli Lilly said that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by President Trump has been paused because of a safety concern https://t.co/bOSVYyTJFE $LLY pic.twitter.com/yekqqn58Qe
by ARGeezer - Oct 24 25 comments
by Frank Schnittger - Oct 23 83 comments
by ARGeezer - Oct 22 5 comments
by ATinNM - Oct 19 54 comments
by Frank Schnittger - Oct 19 123 comments
by Frank Schnittger - Oct 11 38 comments
by Frank Schnittger - Oct 8 126 comments
by Frank Schnittger - Oct 6 167 comments
by ARGeezer - Oct 2425 comments
by Frank Schnittger - Oct 2383 comments
by ARGeezer - Oct 225 comments
by ATinNM - Oct 1954 comments
by Frank Schnittger - Oct 19123 comments
by gmoke - Oct 15
by Frank Schnittger - Oct 1138 comments
by Frank Schnittger - Oct 8126 comments
by Frank Schnittger - Oct 6167 comments
by Frank Schnittger - Oct 135 comments
by IdiotSavant - Sep 286 comments